Cargando…
The Prevalence of Autoantibodies in Complex Regional Pain Syndrome Type I
Autoimmunity has been suggested as one of the pathophysiologic mechanisms that may underlie complex regional pain syndrome (CRPS). Screening for antinuclear antibodies (ANA) is one of the diagnostic tests, which is usually performed if a person is suspected to have a systemic autoimmune disease. Ant...
Autores principales: | Dirckx, Maaike, Schreurs, Marco W. J., de Mos, Marissa, Stronks, Dirk L., Huygen, Frank J. P. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337272/ https://www.ncbi.nlm.nih.gov/pubmed/25741131 http://dx.doi.org/10.1155/2015/718201 |
Ejemplares similares
-
Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome: A Pathogenic Role for T-Lymphocytes?
por: Bharwani, Krishna D., et al.
Publicado: (2017) -
Effect of intravenous low‐dose S‐ketamine on pain in patients with Complex Regional Pain Syndrome: A retrospective cohort study
por: Mangnus, Thomas J. P., et al.
Publicado: (2021) -
Highlighting the Role of Biomarkers of Inflammation in the Diagnosis and Management of Complex Regional Pain Syndrome
por: Bharwani, Krishna D., et al.
Publicado: (2019) -
Effectiveness of Infliximab in Patients with Complex Regional Pain Syndrome: A Case Series
por: van den Berg, Corinne, et al.
Publicado: (2023) -
From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome
por: Mangnus, Thomas J. P., et al.
Publicado: (2022)